Anti-IDH1 monoclonal antibody
Pre-made anti-IDH1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to IDH1/IDH1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-T69563-Ab-1/ GM-Tg-hg-T69563-Ab-2 | Anti-Human IDH1 monoclonal antibody | Human |
GM-Tg-rg-T69563-Ab-1/ GM-Tg-rg-T69563-Ab-2 | Anti-Rat IDH1 monoclonal antibody | Rat |
GM-Tg-mg-T69563-Ab-1/ GM-Tg-mg-T69563-Ab-2 | Anti-Mouse IDH1 monoclonal antibody | Mouse |
GM-Tg-cynog-T69563-Ab-1/ GM-Tg-cynog-T69563-Ab-2 | Anti-Cynomolgus/ Rhesus macaque IDH1 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-T69563-Ab-1/ GM-Tg-felg-T69563-Ab-2 | Anti-Feline IDH1 monoclonal antibody | Feline |
GM-Tg-cang-T69563-Ab-1/ GM-Tg-cang-T69563-Ab-2 | Anti-Canine IDH1 monoclonal antibody | Canine |
GM-Tg-bovg-T69563-Ab-1/ GM-Tg-bovg-T69563-Ab-2 | Anti-Bovine IDH1 monoclonal antibody | Bovine |
GM-Tg-equg-T69563-Ab-1/ GM-Tg-equg-T69563-Ab-2 | Anti-Equine IDH1 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-T69563-Ab-1/ GM-Tg-hg-T69563-Ab-2; GM-Tg-rg-T69563-Ab-1/ GM-Tg-rg-T69563-Ab-2; GM-Tg-mg-T69563-Ab-1/ GM-Tg-mg-T69563-Ab-2; GM-Tg-cynog-T69563-Ab-1/ GM-Tg-cynog-T69563-Ab-2; GM-Tg-felg-T69563-Ab-1/ GM-Tg-felg-T69563-Ab-2; GM-Tg-cang-T69563-Ab-1/ GM-Tg-cang-T69563-Ab-2; GM-Tg-bovg-T69563-Ab-1/ GM-Tg-bovg-T69563-Ab-2; GM-Tg-equg-T69563-Ab-1/ GM-Tg-equg-T69563-Ab-2 |
Products Name | Anti-IDH1 monoclonal antibody |
Format | mab |
Target Name | IDH1 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | Therapeutics Target antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-IDH1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-T69563-Ag-1 | Recombinant multi-species IDHC/ IDH1/ HEL-216 protein |
ORF Viral Vector | vGMLV000343 | human IDH1 Lentivirus particle |
ORF Viral Vector | pGMAD000601 | human IDH1 Adenovirus plasmid |
ORF Viral Vector | pGMLV000345 | human IDH1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000644 | human IDH1 Lentivirus plasmid |
ORF Viral Vector | pGMLV000344 | human IDH1 Lentivirus plasmid |
ORF Viral Vector | vGMLV000644 | human IDH1 Lentivirus particle |
ORF Viral Vector | vGMLV000345 | human IDH1 Lentivirus particle |
ORF Viral Vector | pGMLV000343 | human IDH1 Lentivirus plasmid |
ORF Viral Vector | vGMLV000344 | human IDH1 Lentivirus particle |
ORF Viral Vector | vGMAD000601 | human IDH1 Adenovirus particle |
ORF Viral Vector | pGMLPm001512 | mouse Idh1 Lentivirus plasmid |
ORF Viral Vector | vGMLPm001512 | mouse Idh1 Lentivirus particle |
Target information
Target ID | GM-T69563 |
Target Name | IDH1 |
Gene ID | 3417,15926,24479,710019,478889,751618,281235,100066416 |
Gene Symbol and Synonyms | E030024J03Rik,HEL-216,HEL-S-26,Id-1,IDCD,IDH,Idh-1,IDH1,IDP,IDPC,PICD |
Uniprot Accession | O75874,P41562,Q9XSG3 |
Uniprot Entry Name | IDHC_HUMAN,IDHC_RAT,IDHC_BOVIN |
Protein Sub-location | Introcelluar Protein |
Category | Therapeutics Target, Immuno-oncology Target |
Disease | Ovary Cancer |
Gene Ensembl | ENSG00000138413 |
Target Classification | Checkpoint-Immuno Oncology |
The target: IDH1, gene name: IDH1, also named as HEL-216, HEL-S-26, IDCD, IDH, IDP, IDPC, PICD. Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the cytoplasm and peroxisomes. It contains the PTS-1 peroxisomal targeting signal sequence. The presence of this enzyme in peroxisomes suggests roles in the regeneration of NADPH for intraperoxisomal reductions, such as the conversion of 2, 4-dienoyl-CoAs to 3-enoyl-CoAs, as well as in peroxisomal reactions that consume 2-oxoglutarate, namely the alpha-hydroxylation of phytanic acid. The cytoplasmic enzyme serves a significant role in cytoplasmic NADPH production. Alternatively spliced transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Sep 2013].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.